- Home
- FG vs ZLAB Comparison
FG vs ZLAB Comparison
Compare FG & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FG
- ZLAB
- Stock Information
- Founded
- FG 1959
- ZLAB 2013
- Country
- FG United States
- ZLAB China
- Employees
- FG N/A
- ZLAB N/A
- Industry
- FG Life Insurance
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- FG Finance
- ZLAB Health Care
- Exchange
- FG Nasdaq
- ZLAB Nasdaq
- Market Cap
- FG 4.3B
- ZLAB 4.3B
- IPO Year
- FG N/A
- ZLAB 2017
- Fundamental
- Price
- FG $31.97
- ZLAB $37.80
- Analyst Decision
- FG Hold
- ZLAB Buy
- Analyst Count
- FG 3
- ZLAB 5
- Target Price
- FG $43.33
- ZLAB $54.28
- AVG Volume (30 Days)
- FG 161.2K
- ZLAB 818.7K
- Earning Date
- FG 08-06-2025
- ZLAB 08-07-2025
- Dividend Yield
- FG 2.76%
- ZLAB N/A
- EPS Growth
- FG 91.46
- ZLAB N/A
- EPS
- FG 3.84
- ZLAB N/A
- Revenue
- FG $5,139,000,000.00
- ZLAB $418,326,000.00
- Revenue This Year
- FG N/A
- ZLAB $44.07
- Revenue Next Year
- FG $19.03
- ZLAB $49.13
- P/E Ratio
- FG $8.32
- ZLAB N/A
- Revenue Growth
- FG N/A
- ZLAB 43.72
- 52 Week Low
- FG $30.01
- ZLAB $16.01
- 52 Week High
- FG $50.75
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- FG 52.45
- ZLAB 54.31
- Support Level
- FG $30.56
- ZLAB $36.51
- Resistance Level
- FG $32.71
- ZLAB $41.20
- Average True Range (ATR)
- FG 0.80
- ZLAB 1.20
- MACD
- FG 0.10
- ZLAB 0.33
- Stochastic Oscillator
- FG 72.73
- ZLAB 56.49
About FG F&G Annuities & Life Inc.
F&G Annuities & Life Inc is a provider of insurance solutions serving retail annuity and life customers as well as institutional clients. Through its insurance subsidiaries, including FGL Insurance and Fidelity & Guaranty Life Insurance Company of New York it markets a broad portfolio of deferred annuities (fixed indexed annuities (FIAs) and multi-year guarantee annuities (MYGAs) or other fixed rate annuities), immediate annuities, indexed universal life (IUL) insurance, funding agreements through funding agreement-backed notes (FABN) issuances and the Federal Home Loan Bank of Atlanta (FHLB)), and pension risk transfer (PRT) solutions.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.